| Literature DB >> 9365241 |
Y Huang1, Z M Yuan, T Ishiko, S Nakada, T Utsugisawa, T Kato, S Kharbanda, D W Kufe.
Abstract
Treatment of cells with the antimetabolite 1-beta-D-arabinofuranosylcytosine (ara-C) and other genotoxic agents is associated with activation of the c-Abl protein tyrosine kinase. The functional role of c-Abl in the response to DNA damage, however, remains unclear. The present studies demonstrate that cells expressing a dominant negative, kinase-inactive c-Abl (K-R) are resistant to killing by ara-C. The expression of c-Abl (K-R) blocked ara-C-induced apoptosis by a mechanism that is at least in part independent of the p53 tumor suppressor. Cells null for c-Abl also exhibited resistance to induction of apoptosis. These findings provide support for a pro-apoptotic function of c-Abl in the response to certain genotoxic drugs.Entities:
Mesh:
Substances:
Year: 1997 PMID: 9365241 DOI: 10.1038/sj.onc.1201376
Source DB: PubMed Journal: Oncogene ISSN: 0950-9232 Impact factor: 9.867